The Troutman Sanders Tobacco Team will attend the Food and Drug Law Institute Tobacco and Nicotine Products Regulation and Policy Conference in Washington, D.C. October 24-25, 2019.
A diverse group of stakeholders, including manufacturers, governmental agencies, researchers and public health advocates, will meet to discuss effective regulation of the broad spectrum of tobacco and nicotine products. FDA’s Center for Tobacco Products Director Mitch Zeller will provide an update on regulations, guidance documents and other initiatives.
Bryan Haynes will moderate a panel entitled “Marketing and Advertising for Modified Risk Tobacco Products.” Panelists will discuss how modified risk tobacco products (MRTPs) should be marketed and advertised to adults, considering both their value as alternatives to combustible products and the interest in preventing youth use. Panelists will discuss FDA’s perspective on modified risk claims, the potential value of these claims, the information and misinformation being shared via marketing channels, and offer industry perspectives on how modified risk product claims should be approached.
We look forward to seeing our clients and friends at the conference.